Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction-Reference-Cited by-同舟云学术

Prognostic value of novel cardiovascular magnetic resonance transit times beyond the pulmonary circulation in patients with ventricular dysfunction

Published:2024-08-30 Issue: Volume: Page:
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Sevilla Teresa^ORCID,Baladrón Carlos,de Miguel-Álava María,Rojas-Lavado Gino,González-Bartol Esther,Revilla-Orodea Ana,Aristizabal-Duque Cristhian,Carrasco-Moraleja Manuel,Fernández-Garrote Miguel,San Román J. Alberto

Funder

Gerencia Regional de Salud de Castilla y León

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00330-024-11045-3.pdf

Reference19 articles.

1. Zierler K (2000) Indicator dilution methods for measuring blood flow, volume, and other properties of biological systems: a brief history and memoir. Ann Biomed Eng 28:836–848

2. Müller HM, Tripolt MB, Rehak PH, Groell R, Rienmüller R, Tscheliessnigg KH (2000) Noninvasive measurement of pulmonary vascular resistances by assessment of cardiac output and pulmonary transit time. Invest Radiol 35:727–731

3. Sergiacomi G, Bolacchi F, Cadioli M et al (2010) Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement. Radiology 254:601–608

4. Hansch A, Heyne JP, Jung C, Wolf G, Pfeil A (2012) Quantitative first pass perfusion in cardiovascular magnetic resonance for determination of peak ventricular transit time—a technique for evaluation of heart function. Eur J Radiol 81:e996–e1001

5. Ricci F, Barison A, Todiere G et al (2018) Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study. Eur Heart J Cardiovasc Imaging 19:896–904